the Web's largest and most informative hair loss web site.


 
hair loss
Home
UK Directory
Treatments
Best Sellers
Hair Loss Options
  Cause of Hair Loss
Womens Hair Loss
Vitamins Etc
Dandruff
Hair Transplants
Hair Problems
Stress
Hair Care
Consultation
Wigs & Toupees
Other Treatments
History
Introduction
Hair Structure
Hair Loss Books
Links
Men's Health
Women's Health

 

 

 

 

 

 
 

 

Propecia

Propecia the only FDA approved
pill to treat Male Pattern Baldness.     

 Approx $60/£42 per Month

As Europe's largest hair loss web site we obtain hair loss treatments at the best prices.


Europe and UK

Worldwide
 
 


Photos from Clinical Trials | Propecia FAQ | Results from clinical Studies | Charity Challenge | Propecia Press UK | Porpecia Long Term Test | Porpecia 5 Year Test Results |
How it Works


 

Photos from Clinical Trials | Propecia FAQ | Results from clinical Studies | Charity Challenge | Propecia Press
Propecia Long Term Test

 

Propecia Information (in the news)

The following represent a comprehensive list of articles that address the use of Propecia for hair loss treatment:

New Five-Year Study with Propecia Showed That the `Hair Count' Gap Grew Over Time Between Men Who Treated Hair Loss with Propecia, Compared to Men Who Didn't
PR Newswire
March, 2001

Finasteride Cuts Risk of Further Visible Hair Loss in Men
Doctors Guide News
July, 2002

Finasteride - A Review of Its Use in Male Pattern Hair Loss
Impotence & Male Health Weekly Plus
February, 1999

As Young as You Feel: Weapons to Combat the Effects of Aging
Men's Fitness
Feb, 1999

Information from Your Family Doctor
American Family Physician
April, 1999

Drug Update: Hair Loss in Men
Family Practice news
April , 2001

Alopecia Areata
American Family Physician
April, 1990

The Sex Appeal of Bald Men. (famous African American bald men)
Ebony
March, 1994


 

New Five-Year Study with Propecia Showed That the `Hair Count' Gap Grew Over Time Between Men Who Treated Hair Loss with Propecia, Compared to Men Who Didn't
PR Newswire
March 15, 2001

The longest controlled clinical trial of a hair loss treatment ever reported showed that men who took Propecia(R) (finasteride 1 mg) compared to men who took a placebo had a considerable difference in their hair counts after five years, according to data presented at the 59th Annual Meeting of the American Academy of Dermatology.

The new study showed a difference of 277 hairs in a one-inch diameter circle of scalp in favor of men treated with Propecia for five years (n=219) vs. those who received a placebo (n=15). Baseline hair counts of all men at the start of the study averaged 876 hairs in the one-inch diameter circle.

"This study provides new, long-term scientific data that Propecia helped the majority of men with predominantly vertex male pattern hair loss keep the amount of hair they have," said Keith Kaufman, M.D., senior director, Clinical Research, Merck Research Laboratories. "The study also was the first controlled clinical trial to evaluate the course of untreated hair loss over a five-year period and to show the progressive nature of male pattern hair loss."

Made by Merck & Co., Inc., Propecia is indicated for the treatment of certain types of hair loss in men only, based upon two-year studies. Propecia is a once-a-day treatment and is the only pill for male pattern hair loss approved by the Food and Drug Administration. Hair loss affects approximately 30 million men in the United States. Propecia is not indicated for use in women or children.

The five-year data are from investigational extension studies of double- blind placebo-controlled clinical trials that first demonstrated the safety and efficacy of Propecia in 1,553 men age 18 to 41 with mild-to-moderate male pattern hair loss (androgenetic alopecia) in the vertex region (top of the head). Efficacy in bi-temporal recession (hair loss at the temples) has not been established.

Men who entered the initial 12-month studies of Propecia were randomized to receive either Propecia (n=779) or placebo (n=774). The initial 12-month studies were extended on an annual basis, with only a small number of men remaining on placebo in subsequent years, as specified in the study design. Men who completed each one-year extension were given the opportunity to enroll in the next one-year extension, for up to five years. The five-year data presented focused on the results of men who continued on the same therapy -- either Propecia or placebo -- for the entire five years.

Five-year efficacy results

The studies assessed the efficacy of Propecia by four separate endpoints: hair counts in a one-inch diameter circle of the scalp; assessments of "before" and "after" photographs by a panel of dermatologists; patient questionnaires and investigator assessments of changes in scalp hair growth. The effectiveness of Propecia vs. placebo was demonstrated as follows:

-- Hair count: At the start of the studies, baseline hair counts averaged 876 hairs in a one-inch diameter area of scalp. By the end of the first year, men taking Propecia had an average of 126 more hairs than men taking placebo. This difference continued to grow, and, by the end of the fifth year, the net difference between the groups increased to 277 hairs in favor of the men taking Propecia. At the end of the fifth year, 65 percent of men taking Propecia (n=219) maintained or improved their hair count compared to their hair count at the start of the studies, while all of the men on placebo (n=15) lost hair count.

-- Before and after photos: The panel of dermatologists who reviewed standardized clinical photographs of men treated with Propecia (n=279) and men on placebo (n=16) at the end of the five-year study rated 90 percent of men treated with Propecia as having had no further visible hair loss compared to baseline vs. 25 percent of men on placebo.

-- Patient questionnaires: Questionnaires completed at five years by men on Propecia (n=284) and by men on placebo (n=15) showed that men treated with Propecia indicated a higher level of satisfaction with the appearance of: their hair overall (63 percent vs. 20 percent), the hair on top of their heads (59 percent vs. 13 percent) and their frontal hairline (48 percent vs. 7 percent). Men treated with Propecia were more likely to say that: their bald spot was getting smaller (61 percent vs. 20 percent); the appearance of their hair had improved (77 percent vs. 40 percent); they had experienced increased hair growth (75 percent vs. 40 percent) and their hair loss had slowed (90 percent vs. 67 percent).

-- Investigator assessments: Physician investigators who evaluated the men treated with Propecia (n=279) and men on placebo (n=13) at the end of five years determined that 77 percent of the men treated with Propecia had increases in scalp hair, compared with 15 percent of men on placebo.

Five-year safety profile

The five-year study confirmed the excellent safety profile of Propecia. In the initial 12-month clinical studies, the following side effects were the most common and reported by a very small number of men: less desire for sex (1.8 percent vs. 1.3 percent on placebo), difficulty in achieving an erection (1.3 percent vs. 0.7 percent on placebo) and a decrease in the amount of semen (0.8 percent vs. 0.4 percent on placebo). These sexual side effects went away in all men who discontinued therapy because of them and also disappeared in most (56 percent men who chose to continue taking Propecia through the fifth year of the study. By the end of the fifth year, the incidence of those side effects was less than or equal to 0.3 percent in men who continued treatment with Propecia vs. men on placebo.

Important information about Propecia

Propecia is not for use in women or children. Further, women must not use Propecia when they are or may potentially be pregnant because it may cause abnormalities of the male baby's sex organs. In addition, women should not handle crushed or broken tablets when they are pregnant or may potentially be pregnant.

Propecia tablets are coated, which will prevent contact with the active ingredient during normal handling provided that the tablets have not been broken or crushed.

If the treatment does not show results within 12 months, further treatment is unlikely to be of benefit. If treatment is stopped, the hair that is gained will gradually be lost.

Propecia was approved by the FDA in December 1997 and is currently available in 53 countries worldwide.

Additional resources

Men seeking additional information about hair loss and Propecia can visit http://www.propecia.com/
 
The website also includes a morphing device to allow men to view how they might look if their hair loss progresses. Only a doctor can determine if Propecia is right for an individual.

Merck & Co., Inc. (NYSE: MRK) is a leading research-driven pharmaceutical products and services company. Merck discovers, develops, manufactures and markets a broad range of innovative products to improve human and animal health, directly and through its joint ventures. Merck-Medco Managed Care manages pharmacy benefits for employers, insurers and other plan sponsors, encouraging the appropriate use of medicines and providing disease management programs. Through these complementary capabilities, Merck works to improve the quality of life and contain overall health-care costs.

Propecia(R) is the Merck registered trademark for finasteride 1 mg.

PROPECIA

(Finasteride) Tablets

Patient Information about

PROPECIA(R) (Pro-pee-sha)

Generic name: finasteride (fin-AS-tur-eyed)

PROPECIA is for use by MEN ONLY.

Please read this leaflet before you start taking PROPECIA. Also, read the information included with PROPECIA each time you renew your prescription, just in case anything has changed. Remember, this leaflet does not take the place of careful discussions with your doctor. You and your doctor should discuss PROPECIA when you start taking your medication and at regular checkups.

What is PROPECIA used for?

PROPECIA is used for the treatment of male pattern hair loss on the vertex and the anterior mid-scalp area.

PROPECIA is for use by MEN ONLY and should NOT be used by women or children.

What is male pattern hair loss?

Male pattern hair loss is a common condition in which men experience thinning of the hair on the scalp. Often, this results in a receding hairline and/or balding on the top of the head. These changes typically begin gradually in men in their 20s.

Doctors believe male pattern hair loss is due to heredity and is dependent on hormonal effects. Doctors refer to this type of hair loss as androgenetic alopecia.
Results of clinical studies:

For 12 months, doctors studied over 1800 men aged 18 to 41 with mild to moderate amounts of ongoing hair loss. All men, whether receiving PROPECIA or placebo (a pill containing no medication) were given a medicated shampoo (Neutrogena T/Gel(R) Shampoo). Of these men, approximately 1200 with hair loss at the top of the head were studied for an additional 12 months. In general, men who took PROPECIA maintained or increased the number of visible scalp hairs and noticed improvement in their hair in the first year, with the effect maintained in the second year. Hair counts in men who did not take PROPECIA continued to decrease.

In one study, patients were questioned on the growth of body hair. PROPECIA did not appear to affect hair in places other than the scalp.

Will PROPECIA work for me?

For most men, PROPECIA increases the number of scalp hairs, helping to fill in thin or balding areas of the scalp. Men taking PROPECIA noted a slowing of hair loss during two years of use. Although results will vary, generally you will not be able to grow back all of the hair you have lost. There is not sufficient evidence that PROPECIA works in the treatment of receding hairline in the temporal area on both sides of the head.

Male pattern hair loss occurs gradually over time. On average, healthy hair grows only about half an inch each month. Therefore, it will take time to see any effect.

You may need to take PROPECIA daily for three months or more before you see a benefit from taking PROPECIA. PROPECIA can only work over the long term if you continue taking it. If the drug has not worked for you in twelve months, further treatment is unlikely to be of benefit. If you stop taking PROPECIA, you will likely lose the hair you have gained within 12 months of stopping treatment. You should discuss this with your doctor.

How should I take PROPECIA?

Follow your doctor's instructions.

-- Take one tablet by mouth each day.

-- You may take PROPECIA with or without food.

-- If you forget to take PROPECIA, do not take an extra tablet. Just take the next tablet as usual.

PROPECIA will not work faster or better if you take it more than once a day.

Who should NOT take PROPECIA?

-- PROPECIA is for the treatment of male pattern hair loss in MEN ONLY and should not be taken by women or children.

-- Anyone allergic to any of the ingredients.

A warning about PROPECIA and pregnancy.

-- Women who are or may potentially be pregnant:

-- must not use PROPECIA

-- should not handle crushed or broken tablets of PROPECIA.

If a woman who is pregnant with a male baby absorbs the active ingredient in PROPECIA, either by swallowing or through the skin, it may cause abnormalities of a male baby's sex organs. If a woman who is pregnant comes into contact with the active ingredient in PROPECIA, a doctor should be consulted. PROPECIA tablets are coated and will prevent contact with the active ingredient during normal handling, provided that the tablets are not broken or crushed.

What are the possible side effects of PROPECIA?

Like all prescription products, PROPECIA may cause side effects. In clinical studies, side effects from PROPECIA were uncommon and did not affect most men. A small number of men experienced certain sexual side effects. These men reported one or more of the following: less desire for sex; difficulty in achieving an erection; and, a decrease in the amount of semen. Each of these side effects occurred in less than 2% of men. These side effects went away in men who stopped taking PROPECIA. They also disappeared in most men who continued taking PROPECIA.

In general use, the following have been reported infrequently: allergic reactions including rash, itching, hives and swelling of the lips and face; problems with ejaculation; breast tenderness and enlargement; and testicular pain.

Tell your doctor promptly about these or any other unusual side effects.

-- PROPECIA can affect a blood test called PSA (Prostate-Specific
Antigen) for the screening of prostate cancer. If you have a PSA test
done, you should tell your doctor that you are taking PROPECIA.

Storage and handling.

Keep PROPECIA in the original container and keep the container closed. Store it in a dry place at room temperature. PROPECIA tablets are coated and will prevent contact with the active ingredient during normal handling, provided that the tablets are not broken or crushed.

Do not give your PROPECIA tablets to anyone else. It has been prescribed only for you. Keep PROPECIA and all medications out of the reach of children.

THIS LEAFLET PROVIDES A SUMMARY OF INFORMATION ABOUT PROPECIA. IF AFTER READING THIS LEAFLET YOU HAVE ANY QUESTIONS OR ARE NOT SURE ABOUT ANYTHING, ASK YOUR DOCTOR.

1-888-637-2522, Monday through Friday, 8:30 A.M. TO 7:00 P.M. (ET).

Issued May 2000 MERCK & CO., INC.
Whitehouse Station, NJ 08889, USA
* Registered trademark of MERCK & CO., Inc.
** Registered trademark of MERCK & CO., Inc.
*** Registered trademark of Johnson & Johnson


 

Finasteride Cuts Risk of Further Visible Hair Loss in Men
Doctors Guide News
July, 2002

In men with androgenetic alopecia, treatment with finasteride 1 mg/d for five years leads to a marked and sustained reduction in the risk of developing further visible hair loss.

The findings were reported here at the 20 th World Congress of Dermatology (WCD).

In two replicate, double-blind studies, men aged 18 to 41 years with androgenetic alopecia (AGA) received finasteride 1 mg or placebo for up to five years. Global photographic assessment of scalp hair growth by an expert panel showed the superiority of finasteride over placebo.

In a post-hoc analysis, Dr. Keith Kaufman, of Merck Research Laboratories in Rahway, New Jersey, United States, and colleagues examined the effect of finasteride on the five-year risk of developing further hair loss based on these GPA data.

The analysis included 713 patients who received finasteride 1 mg/day (645 patients) or placebo (68 patients) continuously from randomisation to study completion or discontinuation. All patients underwent global photographic assessments during the five-year study period.

Finasteride treatment led to a 93 percent reduction in the risk of developing further visible hair loss from baseline to end point, relative to placebo. Development of further visible hair loss was observed in the majority of placebo-treated patients by year 3.

The highest rates of further visible hair loss for placebo patients occurred in men of younger age, earlier onset of hair loss, longer duration of hair loss, more severe hair loss pattern, and/or parental history of hair loss.

"These findings suggest that there are differences among men with [androgenetic alopecia] with respect to susceptibility of scalp hair follicles to continued follicular miniaturization," Dr. Kaufman said.
Regardless of the subgroup examined, treatment with finasteride reduced the risk of further visible hair loss relative to placebo, confirming the key role of dihydrotestosterone produced by type II 5 alpha-reductase in mediating hair loss in men with androgenetic alopecia, he added.

The study was supported by Merck Research Laboratories.

 


 

Finasteride - A Review of Its Use in Male Pattern Hair Loss
Impotence & Male Health Weekly Plus
February 1999

According to the authors' abstract of an article published in Drugs, "The 5 alpha-reductase inhibitor finasteride blocks the conversion of testosterone to dihydrotestosterone (DHT), the androgen responsible for male pattern hair loss (androgenetic alopecia) in genetically predisposed men.  Results of Phase III clinical studies in 1,879 men have shown that oral finasteride 1 mg/day promotes hair growth and prevents further hair loss in a significant proportion of men with male pattern hair loss. 

Evidence suggests that the improvement in hair count reported after one year is maintained during two years' treatment. In men with vertex hair loss, global photographs showed improvement in air growth in 48% of finasteride recipients at one year and in 66% at two years compared with 7% of placebo recipients at each time point.  Furthermore, hair counts in these men showed that 83% of finasteride versus 28% of placebo recipients had no further hair loss compared with baseline after two years. 

The clinical efficacy of oral finasteride has not yet been compared with that of topical minoxidil, the only other drug used clinically in patients with male pattern hair loss.  Therapeutic dosages of finasteride are generally well tolerated. In Phase III studies, 7.7% of patients receiving finasteride 1 mg/day compared with 7.0% of those receiving placebo reported treatment-related adverse events.  The overall incidence of sexual function disorders, comprising decreased libido, ejaculation disorder, and erectile dysfunction, was significantly greater in finasteride than placebo recipients (3.23 vs. 2.1%).  All sexual adverse events were reversed on discontinuation of therapy and many resolved in patients who continued therapy.  No other drug-related events were reported with an incidence > =1% in patients receiving finasteride.  Most events were of mild moderate severity. Oral finasteride is contraindicated in pregnant women because of the risk of hypospadias in male fetuses. 

CONCLUSIONS: Oral finasteride promotes scalp hair growth and prevents further hair loss in a significant proportion of men with male pattern hair loss.  With its generally good tolerability profile, finasteride is a new approach to the management of this condition, for which treatment options are few.  Its role relative to topical minoxidil has yet to be determined."  The corresponding author for this study is: KJ Mcclellan, Adis Int Ltd, 41 Centorian Dr, Private Bag 65901, Auckland 10, New Zealand.  For subscription information for this journal, contact the publisher: Adis International Ltd, 41 Centorian Dr, Private Bag 65901, Mairangi Bay, Auckland 10, New Zealand.

 


 

As Young as You Feel: Weapons to Combat the Effects of Aging
Men's Fitness
February, 1999

You go to the gym and pump iron until your arms are so sore that you can't even scratch your back. You do cardio work until your heart feels like it's going to thump out of your chest. You're careful to eat the right foods and get enough rest. And yet, you're still at risk for looking old before your time.

See, at the same time you're working so hard to take care of your body's insides, the sun and other factors are conspiring to damage its outside - your skin and hair. Even if you haven't noticed any wrinkles, your skin may already be damaged, especially if you had serious sunburns or spent a lot of time outdoors in your youth.

Being concerned about the condition of your skin and hair isn't mere vanity. Like it or not, staying young and vibrant in attitude as well as appearance can help your career. And in a competitive workforce, any edge can make a difference. So, to provide you with some guidance, we've consulted dermatologists on the Men's Fitness Advisory Board to bring you the anti-aging products that can help slow the effects of Father Time.

Wrinkles away

"Sun is the major culprit, the chief bad actor in aging the skin," says dermatologist Joseph Bark, MD, a fellow of the American Academy of Dermatology and author of Your Skin ... an Owner's Guide (Prentice Hall, $11). "So investing in a bottle of sunscreen is a long-term investment in the health of your skin. The higher the SPF [sun protection factor], the better. We're talking 30- to 50-rated sunscreen."

Coppertone Sport Ultra Sweatproof suntan lotion SPF 30 or 45 ($8 for four ounces) fits the bill and gives long-lasting protection. It's waterproof but not greasy, and it dries quickly.

What's the next best thing to a good sunscreen? Alpha hydroxy acids, according to Bark. "[Alpha-hydroxy-containing products] are extremely efficient at resurfacing the dead layer of the skin and smoothing the skin out," he says. "They also give the skin a certain translucency that's attractive, and they smooth fine lines."

When choosing an alpha hydroxy, look for concentrations of 5 to 8 percent, says Arnold W. Klein, MD, full clinical professor of medicine/dermatology at UCLA Medical Center with a private dermatology practice in Beverly Hills. You can increase the concentration when your skin gets used to the treatment.

Aramis makes an alpha hydroxy called Lift Off!. with SPF 7 protection (two ounces for $28 or 3.4 ounces for $38), and Clinique's alpha hydroxy is called Turnaround Lotion ($25 for 1.7 ounces). If budget is an issue, Klein says you can do just as well with more affordable alpha-hydroxy acids available in your local pharmacy; he recommends products from Alpha Hydrox, NeoStrata and Aqua Glycolic.

Take your vitamins

Another product that can attack wrinkles is Renova ($60 for 40 grams), a topical treatment available by prescription. Renova has the same active ingredient as Retin A, an acidic form of vitamin A used to treat acne, but it's in a base more suitable for sun-damaged skin. Bark says that Renova can help smooth out fine lines. "It can erase small color changes in the skin due to aging and sunlight exposure," he adds. "It resurfaces the skin with a younger population of cells so that it looks smoother, more translucent and much more attractive."

Renova can cause some redness and irritation if you use too much too soon. To give your skin achance to grow accustomed to the treatment, Bark advises patients to use it once every two or three days at first, then increase the frequency over the next couple of months.

Available over-the-counter are retinols, which are the alcoholic derivatives of Retin A, such as Estee Lauder's Diminish ($48 for one ounce) and Prescriptive's LSW ($50 for one ounce). But Klein is skeptical of the effectiveness of retinols. "There is really a paucity of evidence to suggest they are beneficial in causing anti-aging effects topically on the skin," he says.

Other products containing a topical form of vitamin C offer a limited antiaging effect, Klein says. "There are not really any conclusive studies about their efficacy at this point," he says. "I just know that patients who use them really like their ability to make them look better." Vitamin C products from Cellex-C (http://www.cellex-c.com/) and SkinCeuticals (www.skinceuticals.com) are popular with Klein's patients.

Hairs looking at you

For combating hair loss, the prescription medication Propecia ($50 for a one-month supply) claims to possibly even grow hair. "It tends to have men keep their hair in about 80 to 85 percent of the cases," Bark says, "as long as they stay on it. And in about 60 to 63 percent, the guys grow hair back." Side effects include wilted woodies in a small percentage of users.

Klein adds that the topical solution Rogaine ($30 for a one-month supply), has proved a great success, especially now that it's available in a higher concentration of 5 percent. But he cautions against other topical hair-growth promises. "All of these hair products that you hear grow hair are rubbish for the most part," he says. "For something to claim hair growth, it has to have good double-blind studies that show efficacy, and Rogaine has shown that."

For a mild shampoo, Bark recommends Neutrogena ($6 for 6 ounces). What about those shampoos that claim to thicken hair? "They coat the hair with protein, and it feels a little thicker," Bark says. "But you have to watch those a little bit, because you can get build-up."

While most of these products are not cheap, they do hold promise to keep you looking young. And if that's important to you, they just may be worth a closer look.

 


 

Information from Your Family Doctor
American Family Physician
April 15, 1999

Treating Baldness in Men

What is male pattern baldness?

Male pattern baldness is hair loss that happens because the male hormone testosterone (say: tess-toss-ter-own) changes the hair roots.

Can male pattern baldness be treated?

Male pattern baldness doesn't have to be treated, but many men feel better about the way they look if their "bald spot" is covered. Some treatments are minoxidil (brand name: Rogaine), finasteride (brand name: Propecia), hair transplants and toupees (hairpieces).

Which treatment is right for me?

This is a personal decision to make after looking at all of your options. Ask to see "before" and "after" pictures of men who have used the methods you're thinking about trying. Think about these factors: how far along your baldness is; how you feel about having surgery; the cost (both now and in the long term); and how easy it is to use.

Do these medicines cure baldness?

No. Nothing cures baldness. Two medicines can help regrow some lost hair, but not all of it. Finasteride and minoxidil usually regrow only enough hair to cover part of the bald areas. Both of these medicines work better on the crown of the head than on the front hairline.

Will minoxidil or finasteride work for me?

There is no way to predict who will respond to these medicines. It may take up to six months before you can tell if the medicine is working. Men who are younger, who have a smaller bald area and who start using the medicine early may have better results. These medicines may be most helpful for men who have just started balding.

Do these medicines have side effects?

Like all medicines, these medicines cause some side effects. A few men have had sexual side effects (a decrease in sexual urges) from finasteride that went away after they stopped taking the medicine. Minoxidil causes an itchy scalp in a few men. This also goes away when the medicine is stopped.

How do I use these medicines?

Minoxidil is sprayed on and rubbed into the scalp twice a day. Finasteride is a pill you take once a day. Both medicines must be used every day. When you stop taking either medicine, you start to lose hair again.

For more information about balding and treatments, you can visit the Web site of the National Alopecia Areata Foundation at: http://www.alopeciaareata.com/   or phone 415-456-4644.

 


 

Drug Update: Hair Loss in Men
Family Practice news
April, 2001

The treatment of hair loss in men has improved vastly in recent years, thanks mostly to two drugs that promote hair growth and improve the appearance of existing hair: finasteride and minoxidil.
One of two disorders, androgenetic alopecia or alopecia areata, is generally responsible for hair loss in young and middle-aged men.

Androgenetic alopecia, also known as male pattern baldness, causes a characteristic pattern of hair loss, including temporal recession of the hair, thinning of the hair at the frontal and vertex regions of the scalp, and complete loss of hair with the exception of some fringing. It usually begins before the age of 40--sometimes as early as age 12--and it affects about half of the male population before they reach the age of 50.

Finasteride and minoxidil are the only drugs that are approved to treat this type of hair loss, although estradiol has also been used with some success. Both finasteride and minoxidil promote hair growth, slow hair loss, and increase the length and diameter of existing hair.
Alopecia areata, unlike androgenetic alopecia, is assumed to have an autoimmune cause. Patients with this condition may have small patches of hair loss that regrow spontaneously, or they may have extensive patches of hair loss that do not resolve.

Treatment with minoxidil is generally beneficial for stimulating hair growth in men with mild or moderate alopecia areata; a 40% response rate is typical. How ever, minoxidil will not help men with one of the most severe forms of alopecia areata, in which all the scalp hair is lost: alopecia totalis. Anthralin is another main stay of therapy for alopecia areata, as are glucocorticoids, which can be used topically, intralesionally, or orally. The preferred glucocorticoid treatment is intralesional injections of triamcinolone.

Psoralen with ultraviolet A therapy is a more controversial treatment for alopecia areata. Although it works well, long-term therapy is necessary to maintain the effects, and this long-term use may lead to several health problems. Topical immunotherapy is also showing promise for treating alopecia areata and is currently under study. Patients with alopecia areata should be referred to a specialist for treatment.

 


 

Alopecia Areata
American Family Physician
April, 1990

Abstract: Alopecia areata is a condition involving hair loss in one or many areas of the scalp for no identifiable reason.  It can affect men or women, and is most common in people between the ages of 20 and 50.  Sufferers from alopecia totalis lose all their scalp hair, and victims of alopecia universalis lose their body hair.  Alopecia areata usually begins with hair loss in one patch on the scalp, then involves other patches.  Some areas of baldness may regrow hair.  The hairs at the periphery of the widening bald patch are tapered and lighter toward the base and called 'exclamation point' hairs.  Signs of inflammation can be seen in microscopic sections of skin from the affected region.  Alopecia areata may be familial and is associated with certain diseases, such as Down syndrome and certain thyroid diseases.  Nail changes may also occur. 

Since the condition has a high relapse rate, the success rates of different treatments are hard to evaluate.  Triamcinolone acetonide, injected into the affected area, corticosteroids, and minoxidil (Rogaine) are often used.  These agents do not produce continued regrowth after the patient stops using them, and side effects may occur.  An allergic contact dermatitis (local allergic reaction) may also induce hair growth as may the application of ultraviolet irradiation.  Drugs that stimulate the immune system have also been found effective. 

Since alopecia areata leads to physical changes that many people find distressing, physicians should offer support and make patients aware of the support groups that exist.  (Consumer Summary produced by Reliance Medical Information, Inc.) Abstract: Alopecia areata is an asymptomatic, nonscarring hair loss with spontaneous remissions and exacerbations.  Although the etiology is unknown,the disorder is associated with vitiligo, atopy, pernicious anemia, Downsyndrome and thyroiditis.  The area of hair loss may remain localized or mayinvolve the entire scalp or all body hair.  Treatment is difficult to assessbecause of individual response and spontaneous remissions, as well as a highrate of relapse.  intralesional injection of corticosteroids is the most commonmode of treatment, although systemic steroid therapy, contact allergens,minoxidil, psoralens plus ultraviolet light, and other agents have been tried.COPYRIGHT American Academy of Family Physicians 1990

 


 

The Sex Appeal of Bald Men. (famous African American bald men)
Ebony
March 1994

In the ~40s and ~50s, it was pomade-brushed waves that sent women into a blushing frenzy.  later, in the 60s and ~70s, it was the Afro that caused female hearts to flutter.  More recently, men donning curls, dreadlocks or geometric cuts have won the affection of many young women.  But the timeless "do" that has garnered the most faithful group of female fans is the classic bald, clean-as-a-white look.

To many women, nothing is more appealing than a Black man who is confident enough to break with convention and bare a smoothly shaven head.  In their book, bald is beautiful, bold and, more importantly, bodaciously sexy.

The trend may have gotten its start years ago when soulful balladeer Isaac Hayes was popular on the music scene, Harlem Globetrotter Curly Neal wowed audiences on the basketball court and Marvelous Marvin Hagler bullied victims in the boxing ring.  Today an increasing number of African-American men are shaving their heads, making the bald look more popular than ever.  And now, a variety of Black men, from television personalities and film execs to sports stars and recording artists, have adopted the no-hair trend.

For some entertainers, flaunting the  "un-do" is a personal rebellion against America's view that hair should be perfectly coiffed.  For others, it's a matter of fashion.  But for many men, choosing the bald look is simply their way of beating Mother Nature to the draw.  By choice or chance, baldness is, they say, the most convenient style around.

But what do so many women find appealing about the hairless craze? Everything  Jewelry and fashion designer Kim Harris of Atlanta says, "Bald men are powerful and sexy."

Harris and other women say that baldness, by choice or chance, can be a very seductive force that beckons immediate attention. "You know someone is nice looking when they don't have hair and they still look nice,"adds 34-year-old Cheryl Chandler a Xerox account marketing executive in St. Louis.  "I've always been attracted to guys with receding hairlines.  If I walked into a room, I'd notice them first."

Chandler is not alone.  "I think of a bald man as someone who has class, someone who has it all together," says Tina Wimbush, 31, who works for the U.S. Census Bureau in Maryland.

Other women say it's the positive energy that bald men exude that is most attractive.  "Bald men demonstrate confidence and self-assuredness.  And that, coupled with a nicely shaped head, is quite appealing," says Cassandra Bronson, a 40-year-old teacher consultant in Flint, Mich., who is happily married to a bald man.

Yet, other women can't quite pinpoint their intrigue with shiny crowns. "It's something about a bald man that just grabs my attention," says medical center owner Kathy Williamson, 41, of Los Angeles.  "I think you get to the real essence of a man when he's bald. There's not a lot of room for pretense."

This no-nonsense, masculine perception of maneless men is pervasive, relationship experts say.  "For some women, bald men symbolize masculine virility," says Dr. Patricia A. Outlaw, a clinical psychologist in Baltimore.  "It's daring and different to be bald."

Moreover, the difference can be quite enticing for women who feel that men hide behind a veneer of masculine pride.  "Women like to kiss and to touch the bald head.  They see it as a vulnerability in a man," says psychiatrist Gail E. Wyatt, a sex and relationship researcher at UCLA.  "The head is a vulnerable part of the body, so when you expose it, you say, ~I'm up for this.'  Baldness is truly an attention-grabber."

Bald men haven't amassed a large female following because they lack hair.  No, it goes deeper than that.  The clean-shaven men featured here, many women say, are sexy and appealing because they are a perfectly polished package of machismo and maturity, intrigue and integrity, and, most of all, sophistication and sensuality.

 


Europe and UK

Worldwide
 
 

Propecia

Return to Product Reviews

 

Losing hair? get help now from Folica the web's most popular hair loss store.

 

 
 
              || © 2004 - hairloss-prevention.com | Disclaimer | Site Map